Old Web
English
Sign In
Acemap
>
Paper
>
Use of not authorised stem-cell based products: The Committe for Advanced Therapies (CAT) perspective
Use of not authorised stem-cell based products: The Committe for Advanced Therapies (CAT) perspective
2010
Christian K. Schneider
P Salmikangas
Bernd Jilma
Bruno Flamion
Lr Todorova
A Paphitou
I Haunerova
S. Thirstrup
Toivo Maimets
Jh Trouvin
Egbert Flory
Asterios S. Tsiftsoglou
Balázs Sarkadi
K. Gudmundsson
M. ODonovan
G Migliaccio
J Ancans
R. Maciulaitis
Jl Robert
A. Samuel
H Ovelgönne
M Hystad
Am Fal
B. Silva Lima
As Moraru
P Turcani
B Zorec
S. Ruíz
L Akerblom
Gopalan Narayanan
A. Kent
Fabrizia Bignami
G. Dickson
D. Niederwieser
Maf Santos
M. Clausen
J Gulbinovic
M Menezes-Ferreira
M. Timon
Ig Reischl
C Beuneu
R Georgiev
M. Vassiliou
A Pychova
T Methuen
S. Lucas
Kokkas
Z Buzás
N. MacAleenan
Mc Galli
A. Line
Guy Berchem
M. Fraczek
N. Vilceanu
M. Hrubiško
P Marinko
Ws Cheng
Ga Crosbie
N Meade
M. Lipucci Di Paola
Thierry Vandendriessche
P. Ljungman
L DApote
O Oliver-Diaz
I Büttel
Patrick Celis
Keywords:
Stem cell
Pharmacology
Pathology
Medicine
Diabetes mellitus
Intensive care medicine
Surgery
Correction
Source
Cite
Save
Machine Reading By IdeaReader
2
References
13
Citations
NaN
KQI
[]